Venus Remedies has bagged a patent from the United States Patent Office for Achnil, a once-a-day painkiller injection developed by the Venus Medicine Research Centre (VMRC) the R&D wing of Venus Remedies. The patent will remain in force till 2032.
The formulation will be commercialized in the US market through technology transfer/outlicensing of exclusive marketing rights route, and the company is open to such deals. The company has also secured a US Patent for its novel research product Elores, Potentox and Vancoplus.
Venus Remedies is a pharmaceutical manufacturing company. The company provides formulations in area of antibiotics and oncological therapeutics. The company has two manufacturing facilities located in India and Germany. It manufactures Oncological and Cefelosporine Injectable products.
